Vanguard Global Advisers’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$55K Buy
1,133
+681
+151% +$34.5K ﹤0.01% 3040
2026
Q2
$24.4K Hold
452
– – ﹤0.01% 3271
2026
Q1
$29.5K Buy
+452
New +$31.2K ﹤0.01% 3202

Other funds holding SPRB

Vanguard Global Advisers's SPRB Position: Q3 2026 in Review

Vanguard Global Advisers increased its Spruce Biosciences (SPRB) stake by 151% in Q3 2026, buying an estimated $34.5K and bringing the position to 1,133 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Vanguard Global Advisers first reported a position in SPRB in Q1 2026 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • Vanguard Global Advisers held 1,133 shares of Spruce Biosciences worth $55K as of Q3 2026.
  • Vanguard Global Advisers bought 681 Spruce Biosciences shares in Q3 2026, an estimated $34.5K.
  • Spruce Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3040 holding.
  • Vanguard Global Advisers first reported a position in Spruce Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 70 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.